Latest Findings in First Databank Whitepaper: Active CDS Improves Healthcare Outcomes
The whitepaper highlights independent research showing that active CDS improves healthcare outcomes and reduces the occurrence of Adverse Drug Events (ADEs). This is achieved through the use of actionable alerts to highlight drug specific information such as drug-drug interactions, duplicate therapy and drug allergies integrated into a variety of healthcare applications. The full whitepaper can be seen on this page or by visiting www.firstdatabank.ae
Medication management is one such area where CDS has had a positive impact on prescribing behaviour, patient safety and return on investment.
Clinicians in the Middle East are now able to benefit from active CDS from a wide range of healthcare settings such as hospitals, insurance and retail pharmacy by using Middle East Drug Knowledge from FDB. The latest drug knowledgebase includes registered drugs for all countries in the Gulf Cooperation Council and includes many other features.
Darren Nichols is the Managing Director of FDB and says "There is a growing demand for active CDS from healthcare insurers, providers and governments across the Middle East. FDB aims to fill the gap in offering active CDS drug knowledge, services and expert guidance in this area".
First Databank is exhibiting at HIMSS Middle East in Abu Dhabi on 20-21st May on stand 202. For more information visit www.firstdatabank.ae
- ends -
Notes for editors
Tel: + 44 (0)1392 440 127
Whitepaper: "Bytes not Books" http://bit.ly/MiSvir
Images for download
Click on any image to view or download in higher resolution.